Zogenix, Inc. (Nasdaq: ZGNX) today presented data from a one year open label study that demonstrated chronic pain patients who ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE